The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies
出版年份 2020 全文链接
标题
The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies
作者
关键词
-
出版物
NATURE IMMUNOLOGY
Volume 21, Issue 8, Pages 835-847
出版商
Springer Science and Business Media LLC
发表日期
2020-07-21
DOI
10.1038/s41590-020-0728-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- NK cells for cancer immunotherapy
- (2020) Noriko Shimasaki et al. NATURE REVIEWS DRUG DISCOVERY
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
- (2020) Enli Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
- (2020) Ombretta Melaiu et al. Frontiers in Immunology
- Exploiting Human NK Cells in Tumor Therapy
- (2020) Paola Vacca et al. Frontiers in Immunology
- NK cells expressing a chimeric activating receptor eliminate MDSCs and rescue impaired CAR-T cell activity against solid tumors
- (2019) Robin Parihar et al. Cancer Immunology Research
- Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors
- (2019) Gaurav Nayyar et al. Frontiers in Oncology
- Minimal residual disease-directed immunotherapy for high-risk myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation
- (2019) Xiaodong Mo et al. Frontiers of Medicine
- Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells
- (2019) Takahiro Kamiya et al. JOURNAL OF CLINICAL INVESTIGATION
- A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors
- (2019) Salah-Eddine Bentebibel et al. Cancer Discovery
- A gene signature predicting natural killer cell infiltration and improved survival in melanoma patients
- (2019) Joseph Cursons et al. Cancer Immunology Research
- Genetic Reprogramming For NK cell Cancer Immunotherapy with CRISPR /Cas9
- (2019) Lukman O. Afolabi et al. IMMUNOLOGY
- Bispecific antibodies: a mechanistic review of the pipeline
- (2019) Aran F. Labrijn et al. NATURE REVIEWS DRUG DISCOVERY
- TEMPORARY REMOVAL: IFN-γ: A cytokine at the right time, is in the right place
- (2019) J. Daniel Burke et al. SEMINARS IN IMMUNOLOGY
- Natural killer cell recruitment and activation are regulated by CD47 expression in the tumor microenvironment
- (2019) Pulak Ranjan Nath et al. Cancer Immunology Research
- Endometrial Tumor Microenvironment Alters Human NK Cell Recruitment, and Resident NK Cell Phenotype and Function
- (2019) Clara Degos et al. Frontiers in Immunology
- Tuning the Tumor Myeloid Microenvironment to Fight Cancer
- (2019) Nadine S. Jahchan et al. Frontiers in Immunology
- The Natural Cytotoxicity Receptors in Health and Disease
- (2019) Alexander David Barrow et al. Frontiers in Immunology
- Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing
- (2019) Tiziano Ingegnere et al. Frontiers in Immunology
- Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
- (2019) Kyle B. Lupo et al. Cancers
- Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors
- (2019) Ziqing Chen et al. Cancers
- NK Cell Dysfunction and Checkpoint Immunotherapy
- (2019) Jiacheng Bi et al. Frontiers in Immunology
- Progranulin promotes melanoma progression by inhibiting natural killer cell recruitment to the tumor microenvironment
- (2019) Ramouna Voshtani et al. CANCER LETTERS
- Bempegaldesleukin (NKTR-214): a CD-122-biased IL-2 receptor agonist for cancer immunotherapy
- (2019) Stephen K. Doberstein EXPERT OPINION ON BIOLOGICAL THERAPY
- Harnessing Natural Killer Cell Antitumor Immunity: From the Bench to Bedside
- (2019) Karrune V. Woan et al. Cancer Immunology Research
- Monalizumab: inhibiting the novel immune checkpoint NKG2A
- (2019) Thorbald van Hall et al. Journal for ImmunoTherapy of Cancer
- Comprehensive characterization of tumor infiltrating natural killer cells and clinical significance in hepatocellular carcinoma based on gene expression profiles
- (2019) Mei Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- Granulysin: The attractive side of a natural born killer
- (2019) E. Sparrow et al. IMMUNOLOGY LETTERS
- Interleukin‐33 activates and recruits natural killer cells to inhibit pulmonary metastatic cancer development
- (2019) Lu Qi et al. INTERNATIONAL JOURNAL OF CANCER
- Engineering strategies to overcome the current roadblocks in CAR T cell therapy
- (2019) Sarwish Rafiq et al. Nature Reviews Clinical Oncology
- Harnessing NK Cells for Cancer Treatment
- (2019) Paola Minetto et al. Frontiers in Immunology
- A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC): results from the Danish Renal Cancer Group (DaRenCa) study-1
- (2018) Frede Donskov et al. ACTA ONCOLOGICA
- First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
- (2018) Rizwan Romee et al. BLOOD
- NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
- (2018) Jan P. Böttcher et al. CELL
- Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor
- (2018) Alexander D. Barrow et al. CELL
- Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML
- (2018) Andreas T. Björklund et al. CLINICAL CANCER RESEARCH
- Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor–Mediated Natural Killer Cell Function
- (2018) Andrew Stiff et al. CLINICAL CANCER RESEARCH
- Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity
- (2018) Marco Colonna IMMUNITY
- Natural killer cell cytotoxicity and its regulation by inhibitory receptors
- (2018) Santosh Kumar IMMUNOLOGY
- Deep immune profiling by mass cytometry links human T and NK cell differentiation and cytotoxic molecule expression patterns
- (2018) Bertram Bengsch et al. JOURNAL OF IMMUNOLOGICAL METHODS
- ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
- (2018) John M Wrangle et al. LANCET ONCOLOGY
- A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
- (2018) Kevin C. Barry et al. NATURE MEDICINE
- Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity
- (2018) Lucas Ferrari de Andrade et al. SCIENCE
- Interferon γ and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer Immunity
- (2018) Elise Alspach et al. Cold Spring Harbor Perspectives in Biology
- Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy
- (2018) Rajani Ravi et al. Nature Communications
- Clinical and Biologic Correlates of Neurotoxicity Associated with CAR T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia (B-ALL)
- (2018) Bianca D. Santomasso et al. Cancer Discovery
- Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis
- (2018) Ross A. Soo et al. Oncotarget
- CD8 + T cells and NK cells: parallel and complementary soldiers of immunotherapy
- (2018) Jillian Rosenberg et al. Current Opinion in Chemical Engineering
- Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
- (2018) Flávia Castro et al. Frontiers in Immunology
- Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor
- (2018) Silvia Gaggero et al. OncoImmunology
- Cytokine release syndrome
- (2018) Alexander Shimabukuro-Vornhagen et al. Journal for ImmunoTherapy of Cancer
- Innate Lymphoid Cells: 10 Years On
- (2018) Eric Vivier et al. CELL
- Unleashing endogenous TNF-alpha as a cancer immunotherapeutic
- (2018) Steven F. Josephs et al. Journal of Translational Medicine
- Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics
- (2018) Karie Runcie et al. MOLECULAR MEDICINE
- NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines
- (2018) Nadine van Montfoort et al. CELL
- Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
- (2018) Pascale André et al. CELL
- NKG2A, a New Kid on the Immune Checkpoint Block
- (2018) John B. Haanen et al. CELL
- Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells
- (2018) Patrick L. Collins et al. CELL
- High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice
- (2018) Adeline Crinier et al. IMMUNITY
- Metabolic reprogramming of natural killer cells in obesity limits antitumor responses
- (2018) Xavier Michelet et al. NATURE IMMUNOLOGY
- Cancer immunoediting and resistance to T cell-based immunotherapy
- (2018) Jake S. O’Donnell et al. Nature Reviews Clinical Oncology
- Molecular Mechanisms Directing Migration and Retention of Natural Killer Cells in Human Tissues
- (2018) Roberta Castriconi et al. Frontiers in Immunology
- CCR10 activation stimulates the invasion and migration of breast cancer cells through the ERK1/2/MMP-7 signaling pathway
- (2017) Hao-yu Lin et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Control of NK Cell Activation by Immune Checkpoint Molecules
- (2017) Asma Beldi-Ferchiou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- LFA-1 Activation in NK Cells and Their Subsets: Influence of Receptors, Maturation, and Cytokine Stimulation
- (2017) Doris Urlaub et al. JOURNAL OF IMMUNOLOGY
- Engineering Natural Killer Cells for Cancer Immunotherapy
- (2017) Katayoun Rezvani et al. MOLECULAR THERAPY
- Diversity of tissue-resident NK cells
- (2017) Hui Peng et al. SEMINARS IN IMMUNOLOGY
- Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo
- (2017) Stephan Halle et al. TRENDS IN IMMUNOLOGY
- Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis
- (2017) Ewelina Krzywinska et al. Nature Communications
- TGF-β1 Downregulates the Expression of CX3CR1 by Inducing miR-27a-5p in Primary Human NK Cells
- (2017) Stefano Regis et al. Frontiers in Immunology
- Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
- (2017) Veronika Kremer et al. Journal for ImmunoTherapy of Cancer
- Targeting KIR Blockade in Multiple Myeloma: Trouble in Checkpoint Paradise?
- (2016) M. Felices et al. CLINICAL CANCER RESEARCH
- Checkpoint Inhibition of KIR2D with the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients with Myeloma
- (2016) M. Carlsten et al. CLINICAL CANCER RESEARCH
- Targeting natural killer cells in cancer immunotherapy
- (2016) Camille Guillerey et al. NATURE IMMUNOLOGY
- TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
- (2016) Sébastien Viel et al. Science Signaling
- TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
- (2016) Sébastien Viel et al. Science Signaling
- Dysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during Diseases
- (2016) Giovanni Bernardini et al. Frontiers in Immunology
- Human Circulating and Tissue-Resident CD56bright Natural Killer Cell Populations
- (2016) Janine E. Melsen et al. Frontiers in Immunology
- High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer
- (2016) Cheng Sun et al. OncoImmunology
- Toxicity and management in CAR T-cell therapy
- (2016) Challice L Bonifant et al. Molecular Therapy-Oncolytics
- Multiple Myeloma Impairs Bone Marrow Localization of Effector Natural Killer Cells by Altering the Chemokine Microenvironment
- (2015) A. Ponzetta et al. CANCER RESEARCH
- A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma
- (2015) D. M. Benson et al. CLINICAL CANCER RESEARCH
- Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
- (2015) Kevin C. Conlon et al. JOURNAL OF CLINICAL ONCOLOGY
- NK cells require IL-28R for optimal in vivo activity
- (2015) Fernando Souza-Fonseca-Guimaraes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection
- (2015) W. Deng et al. SCIENCE
- Individual Human Cytotoxic T Lymphocytes Exhibit Intraclonal Heterogeneity during Sustained Killing
- (2015) Zilton Vasconcelos et al. Cell Reports
- DNAM-1 Expression Marks an Alternative Program of NK Cell Maturation
- (2015) Ludovic Martinet et al. Cell Reports
- The Emerging Understanding of Myeloid Cells as Partners and Targets in Tumor Rejection
- (2015) M. L. Broz et al. Cancer Immunology Research
- Chemokine Receptor Expression on Normal Blood CD56+NK-Cells Elucidates Cell Partners That Comigrate during the Innate and Adaptive Immune Responses and Identifies a Transitional NK-Cell Population
- (2015) Margarida Lima et al. Journal of Immunology Research
- Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15
- (2014) M. Imamura et al. BLOOD
- Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
- (2014) Miranda L. Broz et al. CANCER CELL
- HLA-G-mediated NK cell senescence promotes vascular remodeling: implications for reproduction
- (2014) Sumati Rajagopalan Cellular & Molecular Immunology
- c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells
- (2014) Rosa Molfetta et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma
- (2014) N. Korde et al. HAEMATOLOGICA
- Tumoral Expression of IL-33 Inhibits Tumor Growth and Modifies the Tumor Microenvironment through CD8+T and NK Cells
- (2014) Xin Gao et al. JOURNAL OF IMMUNOLOGY
- CD56brightPerforinlow Noncytotoxic Human NK Cells Are Abundant in Both Healthy and Neoplastic Solid Tissues and Recirculate to Secondary Lymphoid Organs via Afferent Lymph
- (2014) P. Carrega et al. JOURNAL OF IMMUNOLOGY
- The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
- (2014) Christopher J Chan et al. NATURE IMMUNOLOGY
- NK cell self tolerance, responsiveness and missing self recognition
- (2014) Nataliya Shifrin et al. SEMINARS IN IMMUNOLOGY
- Interleukin-17D Mediates Tumor Rejection through Recruitment of Natural Killer Cells
- (2014) Timothy O’Sullivan et al. Cell Reports
- Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
- (2013) Eric O. Long et al. Annual Review of Immunology
- Classification of human natural killer cells based on migration behavior and cytotoxic response
- (2013) B. Vanherberghen et al. BLOOD
- Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production
- (2013) S. C. C. Chiang et al. BLOOD
- A Chimeric Receptor with NKG2D Specificity Enhances Natural Killer Cell Activation and Killing of Tumor Cells
- (2013) Y.-H. Chang et al. CANCER RESEARCH
- Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin
- (2013) R. Remark et al. CLINICAL CANCER RESEARCH
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Neuroblastoma-Derived TGF- 1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells
- (2013) R. Castriconi et al. JOURNAL OF IMMUNOLOGY
- Imaging burst kinetics and spatial coordination during serial killing by single natural killer cells
- (2013) P. J. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Critical Role of the Tumor Microenvironment in Shaping Natural Killer Cell-Mediated Anti-Tumor Immunity
- (2013) Joanna Baginska et al. Frontiers in Immunology
- Interferon α may be back on track to treat acute myeloid leukemia
- (2013) Evelien L.J.M. Smits et al. OncoImmunology
- A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma
- (2012) D. M. Benson et al. BLOOD
- Blocking the Natural Killer Cell Inhibitory Receptor NKG2A Increases Activity of Human Natural Killer Cells and Clears Hepatitis B Virus Infection in Mice
- (2012) Fenglei Li et al. GASTROENTEROLOGY
- Recruitment of Natural Killer Cells in Advanced Stages of Endogenously Arising B-cell Lymphoma
- (2012) Margarethe Przewoznik et al. JOURNAL OF IMMUNOTHERAPY
- High expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor-infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma
- (2012) Min Ho Park et al. JOURNAL OF SURGICAL ONCOLOGY
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells
- (2011) F. Morandi et al. BLOOD
- Natural killer (NK):dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity
- (2011) Steve C. Lee et al. IMMUNOLOGIC RESEARCH
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response
- (2010) A. Reschner et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Murine CXCR3+CD27bright NK cells resemble the human CD56bright NK-cell population
- (2010) Nicole Marquardt et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Intravital Imaging Reveals Distinct Dynamics for Natural Killer and CD8+ T Cells during Tumor Regression
- (2010) Jacques Deguine et al. IMMUNITY
- Origin and development of dendritic cells
- (2010) Kang Liu et al. IMMUNOLOGICAL REVIEWS
- NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
- (2010) Jeffrey E. Rubnitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
- (2009) F. Romagne et al. BLOOD
- Human melanoma cell secreting human leukocyte antigen–G5 inhibit natural killer cell cytotoxicity by impairing lytic granules polarization toward target cell
- (2009) Emilie Lesport et al. HUMAN IMMUNOLOGY
- Safety analysis ofex vivo-expanded NK and NK-like T cells administered to cancer patients: a Phase I clinical study
- (2009) Lisbeth Barkholt et al. Immunotherapy
- NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs
- (2009) B. Morandi et al. INTERNATIONAL IMMUNOLOGY
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
- (2009) Cameron S. Brandt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Adaptive immune features of natural killer cells
- (2009) Joseph C. Sun et al. NATURE
- Increased Expression of Fractalkine is Correlated with a Better Prognosis and an Increased Number of Both CD8+ T Cells and Natural Killer Cells in Gastric Adenocarcinoma
- (2008) Miki Hyakudomi et al. ANNALS OF SURGICAL ONCOLOGY
- Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56brightCD16− cells and display an impaired capability to kill tumor cells
- (2008) Paolo Carrega et al. CANCER
- NK cells are migrated and indispensable in the anti-tumor activity induced by CCL27 gene therapy
- (2008) Jian-Qing Gao et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Natural Killer Cell Accumulation in Tumors Is Dependent on IFN- and CXCR3 Ligands
- (2008) M. Wendel et al. CANCER RESEARCH
- Interleukin-21 activates human natural killer cells and modulates their surface receptor expression
- (2007) Kresten Skak et al. IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started